Nowadays, due to development of specific molecular studies, CLL can be characterized both by accumulation of mature CD5+/CD19+ B lymphocytes arrested in the G0/G1 phases, as well as by clonal proliferation [2]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.